These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15725956)

  • 1. Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma.
    Chi KH; Liu SJ; Li CP; Kuo HP; Wang YS; Chao Y; Hsieh SL
    J Immunother; 2005; 28(2):129-35. PubMed ID: 15725956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
    Palmer DH; Midgley RS; Mirza N; Torr EE; Ahmed F; Steele JC; Steven NM; Kerr DJ; Young LS; Adams DH
    Hepatology; 2009 Jan; 49(1):124-32. PubMed ID: 18980227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I Trial of Intratumoral Injection of
    Lee JM; Lee MH; Garon E; Goldman JW; Salehi-Rad R; Baratelli FE; Schaue D; Wang G; Rosen F; Yanagawa J; Walser TC; Lin Y; Park SJ; Adams S; Marincola FM; Tumeh PC; Abtin F; Suh R; Reckamp KL; Lee G; Wallace WD; Lee S; Zeng G; Elashoff DA; Sharma S; Dubinett SM
    Clin Cancer Res; 2017 Aug; 23(16):4556-4568. PubMed ID: 28468947
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.
    Rodríguez-Ruiz ME; Perez-Gracia JL; Rodríguez I; Alfaro C; Oñate C; Pérez G; Gil-Bazo I; Benito A; Inogés S; López-Diaz de Cerio A; Ponz-Sarvise M; Resano L; Berraondo P; Barbés B; Martin-Algarra S; Gúrpide A; Sanmamed MF; de Andrea C; Salazar AM; Melero I
    Ann Oncol; 2018 May; 29(5):1312-1319. PubMed ID: 29554212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial.
    Lee WC; Wang HC; Hung CF; Huang PF; Lia CR; Chen MF
    J Immunother; 2005; 28(5):496-504. PubMed ID: 16113606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
    Rozera C; Cappellini GA; D'Agostino G; Santodonato L; Castiello L; Urbani F; Macchia I; Aricò E; Casorelli I; Sestili P; Montefiore E; Monque D; Carlei D; Napolitano M; Rizza P; Moschella F; Buccione C; Belli R; Proietti E; Pavan A; Marchetti P; Belardelli F; Capone I
    J Transl Med; 2015 May; 13():139. PubMed ID: 25933939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report:
    Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
    Front Immunol; 2021; 12():752563. PubMed ID: 35003064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.
    El Ansary M; Mogawer S; Elhamid SA; Alwakil S; Aboelkasem F; Sabaawy HE; Abdelhalim O
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):39-48. PubMed ID: 22886490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
    Sun L; Guo H; Jiang R; Lu L; Liu T; He X
    Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma.
    Shen J; Wang LF; Zou ZY; Kong WW; Yan J; Meng FY; Chen FJ; Du J; Shao J; Xu QP; Ren HZ; Li RT; Wei J; Qian XP; Liu BR
    World J Gastroenterol; 2017 Aug; 23(29):5395-5404. PubMed ID: 28839440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.
    Kumagi T; Akbar SM; Horiike N; Kurose K; Hirooka M; Hiraoka A; Hiasa Y; Michitaka K; Onji M
    Oncol Rep; 2005 Oct; 14(4):969-73. PubMed ID: 16142359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.
    Liu KJ; Wang CC; Chen LT; Cheng AL; Lin DT; Wu YC; Yu WL; Hung YM; Yang HY; Juang SH; Whang-Peng J
    Clin Cancer Res; 2004 Apr; 10(8):2645-51. PubMed ID: 15102666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.
    Banchereau J; Ueno H; Dhodapkar M; Connolly J; Finholt JP; Klechevsky E; Blanck JP; Johnston DA; Palucka AK; Fay J
    J Immunother; 2005; 28(5):505-16. PubMed ID: 16113607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
    Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J
    Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.
    Wei Y; Sticca RP; Holmes LM; Burgin KE; Li J; Williamson J; Evans L; Smith SJ; Stephenson JJ; Wagner TE
    Int J Oncol; 2006 Mar; 28(3):585-93. PubMed ID: 16465362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.